FIGURE

Figure 1

ID
ZDB-FIG-240620-252
Publication
Lee et al., 2024 - Assessment of the Novel Anti-Seizure Potential of Validamycin A Using Zebrafish Epilepsy Model
Other Figures
All Figure Page
Back to All Figure Page
Figure 1

EEG analysis of anti-seizure efficacy of VA in the brains of PTZ-treated zebrafish larvae (A) EEG signals corresponding to PTZ-induced seizure-like activity were recorded in the brains of zebrafish larvae pre-treated with 0, 0.01, 0.1, and 1 μM VA or with 1000 μM VPA for comparison. The total seizure count (a) and cumulative duration of seizures (b) recorded during EEG analyses are shown. We examined 6 to 9 fish in each treatment group for EEG analysis. The results are expressed as the mean ± standard error of the mean (S.E.M.). A one-way analysis of variance (ANOVA) was conducted for statistical analysis, and the significance of the results was confirmed. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; (B) mRNA expression analysis of c-fos in 5 dpf zebrafish larvae using qRT-PCR. Data are presented as mean ± standard error of the mean (S.E.M.). Statistical significance was determined using Student’s t-test. ** p < 0.01, *** p < 0.001; (C) Lateral views of bright-field images of zebrafish embryos treated with VA at various concentrations that showed anti-seizure efficacy. Scale bar = 400 µm. The embryos at 1 dpf (ae) and larvae at 5 dpf (a’e’) showed no observable morphological abnormalities. The experiment was conducted with 24 to 54 fish in each treatment group.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Conditions:
Observed In:
Stage: Day 6

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Molecules